CD9 and colorectal carcinoma: EVs from the plasma donated by healthy donors or patients with CRC‐LMs were isolated using sise exclusion chromatography (Figure 7a) and characterised by NTA as well as via identification of CD9 and flotillin1 (Figure 7b,c).